KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD
Public ClinicalTrials.gov record NCT03460652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Dose-Optimized, Open-Label Safety Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Study identification
- NCT ID
- NCT03460652
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Zevra Therapeutics
- Industry
- Enrollment
- 282 participants
Conditions and interventions
Conditions
Interventions
- KP415 oral capsule Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2018
- Primary completion
- Jun 19, 2019
- Completion
- Jul 8, 2019
- Last update posted
- Jul 18, 2021
2018 – 2019
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research | Little Rock | Arkansas | 72211 | — |
| MCB Clinical Research Centers | Colorado Springs | Colorado | 80910 | — |
| Meridien Research | Bradenton | Florida | 34201 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32256 | — |
| Innovative Clinical Research, Inc. | Lauderhill | Florida | 33319 | — |
| Meridien Research | Maitland | Florida | 32751 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| Capstone Clinical Research | Libertyville | Illinois | 60048 | — |
| Psychiatric Associates | Overland Park | Kansas | 66211 | — |
| Center for Psychiatry and Behavioral Medicine, Inc. | Las Vegas | Nevada | 89128 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Neuro-Behavioral Clinical Research | Canton | Ohio | 44718 | — |
| Midwest Clinical Research Center, LLC | Dayton | Ohio | 45417 | — |
| Oregon Center for Clinical Investigations, Inc. | Portland | Oregon | 97214 | — |
| Oregon Center for Clinical Investigations, Inc. | Salem | Oregon | 97301 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| FutureSearch Trials | Austin | Texas | 78731 | — |
| Bayou City Research, Ltd. | Houston | Texas | 77007 | — |
| Houston Clinical Trials | Houston | Texas | 77098 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03460652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2021 · Synced Jul 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03460652 live on ClinicalTrials.gov.